82 FR 52314 - Advisory Commission on Childhood Vaccines
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration Federal Register Volume 82, Issue 217 (November 13, 2017)
Health Resources and Services Administration
Federal Register Volume 82, Issue 217 (November 13, 2017)
| Page Range | 52314-52314 | |
| FR Document | 2017-24493 |
[Federal Register Volume 82, Number 217 (Monday, November 13, 2017)] [Notices] [Page 52314] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2017-24493] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration Advisory Commission on Childhood Vaccines AGENCY: Health Resources and Services Administration (HRSA), Department of Health and Human Services (HHS). ACTION: Notice of meeting. ----------------------------------------------------------------------- SUMMARY: In accordance with the Federal Advisory Committee Act (FACA), notice is hereby given that a meeting is scheduled for the Advisory Commission on Childhood Vaccines (ACCV). This meeting will be open to the public. Information about the ACCV and the agenda for this meeting can be obtained by accessing the following Web site: http://www.hrsa.gov/advisorycommittees/childhoodvaccines/index.html. DATES: The meeting will be held on December 8, 2017, at 9:00 a.m. ET. ADDRESSES: The address for the meeting is 5600 Fishers Lane, Rockville, MD, Conference Room 5N54. The public can join the meeting by: 1. (In Person) Persons interested in attending the meeting in person are encouraged to submit a written notification to: Annie Herzog, Division of Injury Compensation Programs (DICP), Healthcare Systems Bureau (HSB), HRSA, Room 08N146B, 5600 Fishers Lane, Rockville, Maryland 20857 or email: [email protected]. Since this meeting is to be held in a federal government building, attendees will need to go through a security check to enter the building and participate in the meeting. Written notification is encouraged so that a list of attendees can be provided to make entry through security quicker. Persons may attend in person without providing written notification, but their entry into the building may be delayed due to security checks and the requirement to be escorted to the meeting by a federal government employee. To request an escort to the meeting after entering the building, call Amber Johnson at (301) 443-0129. 2. (Audio Portion) Calling the conference phone number 1-800-369- 1833 and providing the following information: Leader Name: Dr. Narayan Nair. Password: 6706374. 3. (Visual Portion) Connecting to the ACCV Adobe Connect Pro Meeting using the following URL: https://hrsa.connectsolutions.com/accv/ (copy and paste the link into your browser if it does not work directly, and enter as a guest). Participants should call and connect 15 minutes prior to the meeting in order for logistics to be set up. If you have never attended an Adobe Connect meeting, please test your connection using the following URL: https://hrsa.connectsolutions.com/common/help/en/support/meeting_test.htm and get a quick overview by following URL: http://www.adobe.com/go/connectpro_overview. FOR FURTHER INFORMATION CONTACT: Anyone requesting information regarding the ACCV should contact Annie Herzog, Program Analyst, DICP, HRSA in one of three ways: (1) Send a request to the following address: Annie Herzog, Program Analyst, DICP, HSB, HRSA, 5600 Fishers Lane, 08N146B, Rockville, Maryland 20857; (2) call (301) 443-6593; or (3) send an email to [email protected]. The ACCV will meet on Friday, December 8, 2017, beginning at 9:00 a.m. ET in the 5600 Fishers Lane Building, Conference Room 5N54, Rockville, Maryland 20857; however, meeting times and locations could change. For the latest information regarding meeting start time and location, please check the ACCV Web site: http://www.hrsa.gov/advisorycommittees/childhoodvaccines/index.html. SUPPLEMENTARY INFORMATION: The ACCV was established by section 2119 of the Public Health Service Act (the Act) (42 U.S.C. 300aa-19), as enacted by Public Law (Pub. L.) 99-660, and as subsequently amended, and advises the Secretary of HHS (the Secretary) on issues related to implementation of the National Vaccine Injury Compensation Program (VICP). Other activities of the ACCV include: Recommending changes to the Vaccine Injury Table at its own initiative or as the result of the filing of a petition; advising the Secretary in implementing section 2127 of the Act regarding the need for childhood vaccination products that result in fewer or no significant adverse reactions; surveying federal, state, and local programs and activities related to gathering information on injuries associated with the administration of childhood vaccines, including the adverse reaction reporting requirements of section 2125(b) of the Act; advising the Secretary on the methods of obtaining, compiling, publishing, and using credible data related to the frequency and severity of adverse reactions associated with childhood vaccines; consulting on the development or revision of Vaccine Information Statements; and recommending to the Director of the National Vaccine Program research related to vaccine injuries which should be conducted to carry out the VICP. The agenda items for the December 8, 2017, meeting will include, but are not limited to, review of petitions to add injuries to the vaccine injury table, and updates from DICP, Department of Justice (DOJ), National Vaccine Program Office (NVPO), Immunization Safety Office (Centers for Disease Control and Prevention), National Institute of Allergy and Infectious Diseases (National Institutes of Health), and Center for Biologics, Evaluation and Research (Food and Drug Administration). A draft agenda and additional meeting materials will be posted on the ACCV Web site (http://www.hrsa.gov/advisorycommittees/childhoodvaccines/index.html) prior to the meeting. Agenda items are subject to change as priorities dictate. Members of the public will have the opportunity to provide comments. Oral comments will be honored in the order they are requested and may be limited as time allows. Requests to make oral comments or provide written comments to the ACCV should be sent to Annie Herzog using the address and phone number above by December 4, 2017. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify Annie Herzog, using the address and phone number above at least 10 days prior to the meeting. Amy McNulty, Acting Director, Division of the Executive Secretariat. [FR Doc. 2017-24493 Filed 11-9-17; 8:45 am] BILLING CODE 4165-15-P
![52314 Federal Register / Vol. 82, No. 217 / Monday, November 13, 2017 / Notices
or other forms of information 2. (Audio Portion) Calling the the administration of childhood
technology to minimize the information conference phone number 1–800–369– vaccines, including the adverse reaction
collection burden. 1833 and providing the following reporting requirements of section
information: 2125(b) of the Act; advising the
Amy McNulty, Leader Name: Dr. Narayan Nair.
Acting Director, Division of the Executive
Secretary on the methods of obtaining,
Password: 6706374. compiling, publishing, and using
Secretariat. 3. (Visual Portion) Connecting to the
credible data related to the frequency
[FR Doc. 2017–24495 Filed 11–9–17; 8:45 am] ACCV Adobe Connect Pro Meeting
BILLING CODE 4165–15–P using the following URL: https:// and severity of adverse reactions
hrsa.connectsolutions.com/accv/ (copy associated with childhood vaccines;
and paste the link into your browser if consulting on the development or
DEPARTMENT OF HEALTH AND it does not work directly, and enter as revision of Vaccine Information
HUMAN SERVICES a guest). Participants should call and Statements; and recommending to the
connect 15 minutes prior to the meeting Director of the National Vaccine
Health Resources and Services in order for logistics to be set up. If you Program research related to vaccine
Administration have never attended an Adobe Connect injuries which should be conducted to
meeting, please test your connection carry out the VICP.
Advisory Commission on Childhood
Vaccines using the following URL: https:// The agenda items for the December 8,
hrsa.connectsolutions.com/common/ 2017, meeting will include, but are not
AGENCY: Health Resources and Services help/en/support/meeting_test.htm and limited to, review of petitions to add
Administration (HRSA), Department of get a quick overview by following URL: injuries to the vaccine injury table, and
Health and Human Services (HHS). http://www.adobe.com/go/connectpro_ updates from DICP, Department of
ACTION: Notice of meeting. overview. Justice (DOJ), National Vaccine Program
FOR FURTHER INFORMATION CONTACT: Office (NVPO), Immunization Safety
SUMMARY: In accordance with the Anyone requesting information
Federal Advisory Committee Act Office (Centers for Disease Control and
regarding the ACCV should contact Prevention), National Institute of
(FACA), notice is hereby given that a Annie Herzog, Program Analyst, DICP,
meeting is scheduled for the Advisory Allergy and Infectious Diseases
HRSA in one of three ways: (1) Send a (National Institutes of Health), and
Commission on Childhood Vaccines request to the following address: Annie
(ACCV). This meeting will be open to Center for Biologics, Evaluation and
Herzog, Program Analyst, DICP, HSB, Research (Food and Drug
the public. Information about the ACCV HRSA, 5600 Fishers Lane, 08N146B,
and the agenda for this meeting can be Administration). A draft agenda and
Rockville, Maryland 20857; (2) call
obtained by accessing the following additional meeting materials will be
(301) 443–6593; or (3) send an email to
Web site: http://www.hrsa.gov/ posted on the ACCV Web site (http://
aherzog@hrsa.gov.
advisorycommittees/childhoodvaccines/ The ACCV will meet on Friday, www.hrsa.gov/advisorycommittees/
index.html. December 8, 2017, beginning at 9:00 childhoodvaccines/index.html) prior to
DATES: The meeting will be held on a.m. ET in the 5600 Fishers Lane the meeting. Agenda items are subject to
December 8, 2017, at 9:00 a.m. ET. Building, Conference Room 5N54, change as priorities dictate.
ADDRESSES: The address for the meeting Rockville, Maryland 20857; however, Members of the public will have the
is 5600 Fishers Lane, Rockville, MD, meeting times and locations could opportunity to provide comments. Oral
Conference Room 5N54. The public can change. For the latest information comments will be honored in the order
join the meeting by: regarding meeting start time and they are requested and may be limited
1. (In Person) Persons interested in location, please check the ACCV Web as time allows. Requests to make oral
attending the meeting in person are site: http://www.hrsa.gov/ comments or provide written comments
encouraged to submit a written advisorycommittees/childhoodvaccines/ to the ACCV should be sent to Annie
notification to: Annie Herzog, Division index.html. Herzog using the address and phone
of Injury Compensation Programs SUPPLEMENTARY INFORMATION: The ACCV number above by December 4, 2017.
(DICP), Healthcare Systems Bureau was established by section 2119 of the Individuals who plan to attend and
(HSB), HRSA, Room 08N146B, 5600 Public Health Service Act (the Act) (42 need special assistance, such as sign
Fishers Lane, Rockville, Maryland U.S.C. 300aa–19), as enacted by Public language interpretation or other
20857 or email: aherzog@hrsa.gov. Law (Pub. L.) 99–660, and as reasonable accommodations, should
Since this meeting is to be held in a subsequently amended, and advises the notify Annie Herzog, using the address
federal government building, attendees Secretary of HHS (the Secretary) on and phone number above at least 10
will need to go through a security check issues related to implementation of the days prior to the meeting.
to enter the building and participate in National Vaccine Injury Compensation
the meeting. Written notification is Program (VICP). Amy McNulty,
encouraged so that a list of attendees Other activities of the ACCV include: Acting Director, Division of the Executive
can be provided to make entry through Recommending changes to the Vaccine Secretariat.
security quicker. Persons may attend in Injury Table at its own initiative or as [FR Doc. 2017–24493 Filed 11–9–17; 8:45 am]
asabaliauskas on DSKBBXCHB2PROD with NOTICES
person without providing written the result of the filing of a petition; BILLING CODE 4165–15–P
notification, but their entry into the advising the Secretary in implementing
building may be delayed due to security section 2127 of the Act regarding the
checks and the requirement to be need for childhood vaccination
escorted to the meeting by a federal products that result in fewer or no
government employee. To request an significant adverse reactions; surveying
escort to the meeting after entering the federal, state, and local programs and
building, call Amber Johnson at (301) activities related to gathering
443–0129. information on injuries associated with
VerDate Sep<11>2014 18:38 Nov 09, 2017 Jkt 244001 PO 00000 Frm 00051 Fmt 4703 Sfmt 9990 E:\FR\FM\13NON1.SGM 13NON1](https://thefederalregister.org/doc/82_FR_52531/page/1.svg)
Document Created: 2017-11-10 01:18:27
Document Modified: 2017-11-10 01:18:27
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Action | Notice of meeting. | |
| Dates | The meeting will be held on December 8, 2017, at 9:00 a.m. ET. | |
| Contact | Anyone requesting information regarding the ACCV should contact Annie Herzog, Program Analyst, DICP, | |
| FR Citation | 82 FR 52314 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR